The latest headlines across every section, pulled from official and open-access sources.
How you use sunscreens, and what other protective measures you take, make a difference in how well you are able to protect yourself and your family from sunburn, skin cancer, early skin aging and other risks of overexposure to the sun.
Today, the U.S. Food and Drug Administration added bemotrizinol to the list of permitted sunscreen active ingredients, marking a significant milestone in the agency's efforts to advance sunscreen innovation.
The changes support accuracy across diverse patient populations, skin tones and clinical care settings.
by Luigi Russo, Erika Giacobini, Nicolò Lentini, Tommaso Osti, Maud Kamal, Stefania Boccia, Roberta Pastorino Background Molecular Tumor Boards (MTBs) bring together multidisciplinary experts to translate genomic data into clinical decisions in oncology, however, their overall clinical impact remains unclear. The aim of this systematic review is to assess the clinical impact of MTB-recommended therapies on patients with cancer outcomes. Methods and findings In this systematic review and meta-analysis, we searched PubMed, Embase, Scopus, and CENTRAL up to July 2025. We included studies of any…
by Patrick Staunton, Mohammad Adib Makrooni, Master Chisale, Billy Nyambolo, Joseph Wu, Damien McCarthy, Mark Ledwidge, Yasir Bin Nisar, Chris Watson, Balwani Mbakaya, Cathal Seoighe, Joe Gallagher Background Globally, pneumonia remains the single biggest cause of mortality in children under 5 years of age. This study sought to train and test a prediction model for hospitalisation within 7 days after initial presentation in 2- to 59-month-old Malawian children with WHO-defined pneumonia in primary care and compare its performance to existing risk prediction models. Methods and findings BIOTOPE…
SOC 2, HITRUST, and BAAs should be treated as starting points, not trust signals. They tell you what a vendor claims about its controls. They do not tell you whether those controls are actually working today or whether the evidence behind the attestation was real. The post Healthcare’s Assurance Infrastructure Is Broken. The Compliance Industry Built It That Way appeared first on MedCity News .
The true promise of AI lies not in autonomy of either the clinician or machine, but in a balanced collaboration that bolsters the strengths of each. The post Bridging Movement and Machine Learning: How Clinicians Can Harness AI in Practice appeared first on MedCity News .
It’s not hard to understand why patients turn to social media for GLP-1 guidance. The healthcare system leaves a huge gap between getting a prescription and actually understanding how to use it well. The post GLP-1s Are a $70 Billion Market — So Why Are Patients Still Getting Medical Advice From TikTok Influencers? appeared first on MedCity News .
Information related to FDA’s preparation for the seventh reauthorization of PDUFA.
CGMP/Active Pharmaceutical Ingredient (API)/Adulterated
Compounding Pharmacy/Adulterated Drug Products
Request for Records/CGMP/Finished Pharmaceuticals/Adulterated
CGMP/OTC Finished Pharmaceuticals/Adulterated
CGMP/OTC Finished Pharmaceuticals/Adulterated
CGMP/OTC Finished Pharmaceuticals/Adulterated
CGMP/OTC Finished Pharmaceuticals/Adulterated
CGMP/OTC Finished Pharmaceuticals/Adulterated
CGMP/OTC Finished Pharmaceuticals/Adulterated
CGMP/OTC Finished Pharmaceuticals/Adulterated
CGMP/Finished Pharmaceuticals/Adulterated/Unapproved New Drugs/Misbranded
Clinical Investigator
Frequently requested inspection records of foreign pharmaceutical manufacturing facilities
New AI sandbox will help make medicines safer, speed up development, and reduce reliance on animal testing.
As with all medicines, the MHRA will keep the safety and effectiveness of Nipolcalimab under close review.